PPT-BELLE-3: A Phase III Study of

Buparlisib and Fulvestrant in Postmenopausal Women With HR HER2 AItreated Locally Advanced or Metastatic Breast Cancer Who Progressed On or After mTOR Inhibitorbased

buparlisib fulvestrant treatment pfs fulvestrant buparlisib pfs treatment placebo months mtor ctdna inhibitor pik3ca status patients mutant disease prior median progression study

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/721380" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "BELLE-3: A Phase III Study of" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.